Amphastar Pharmaceuticals, Inc.

Rachunek Zysków i Strat


Profil spółki
Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna



Przychody TTM (mln): 721
EBIT TTM (mln): 212
index 0 1 2 3 4 5 6 7 8 9 10 11 12 13
Rok finansowy 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 118 204 230 210 252 255 240 295 322 350 438 499 644 713
Przychód Δ r/r 0.0% 72.6% 12.4% -8.4% 19.5% 1.4% -5.9% 22.7% 9.4% 8.5% 25.1% 14.0% 29.1% 10.6%
Marża brutto 23.7% 44.2% 37.9% 24.4% 30.8% 40.8% 37.8% 36.3% 40.9% 41.0% 45.6% 49.9% 53.4% 52.4%
EBIT (mln) -34 25 17 -18 -7 16 -1 -9 -0 -14 43 79 200 205
EBIT Δ r/r 0.0% -175.7% -31.1% -202.8% -61.6% -327.5% -105.7% 863.5% -99.5% 36376.9% -403.2% 82.6% 153.6% 2.9%
EBIT (%) -28.3% 12.4% 7.6% -8.5% -2.7% 6.1% -0.4% -2.9% -0.0% -4.1% 9.9% 15.8% 31.0% 28.8%
Koszty finansowe (mln) 1 1 1 1 1 1 1 0 0 0 1 2 29 30
EBITDA (mln) -20 40 31 -17 4 16 -6 -9 -0 11 70 107 241 277
EBITDA(%) -17.0% 19.7% 13.7% -8.1% 1.6% 6.1% -2.6% -2.9% -0.0% 3.1% 16.0% 21.5% 37.5% 38.9%
Podatek (mln) -40 8 5 -7 -8 4 -3 -3 14 4 21 23 32 30
Zysk Netto (mln) 8 18 12 -11 -3 11 5 -6 49 1 62 91 138 160
Zysk netto Δ r/r 0.0% 133.4% -34.4% -190.2% -74.0% -477.9% -57.2% -227.3% -952.9% -97.8% 5562.4% 47.1% 50.5% 16.0%
Zysk netto (%) 6.5% 8.9% 5.2% -5.1% -1.1% 4.1% 1.9% -1.9% 15.2% 0.3% 14.2% 18.3% 21.3% 22.4%
EPS 0.97 2.26 1.48 -0.25 -0.062 0.23 0.1 -0.12 1.04 0.0233 1.3 1.88 2.85 3.29
EPS (rozwodnione) 0.97 2.26 1.48 -0.25 -0.062 0.22 0.09 -0.12 0.98 0.0223 1.25 1.74 2.6 3.06
Ilośc akcji (mln) 8 8 8 42 45 45 46 46 47 47 48 49 48 48
Ważona ilośc akcji (mln) 8 8 8 42 45 48 48 46 50 49 50 52 53 52
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD USD